ASCO25,gemcitabine,cisplatin

Mashup Score: 0

Gemcitabine Plus Cisplatin Boosts OS, Resection Rates for Biliary Tract Cancer | GI Oncology Now - 5 day(s) ago

A final analysis of the phase 3 GAIN trial has provided new insight into the efficacy of neoadjuvant/perioperative gemcitabine with cisplatin.

Source: www.gioncologynow.com

Categories: General Medicine News, Partners & KOLs

Tweet Tweets with this article
- GiOncNow
  
  🔎 A final analysis of the phase 3 GAIN trial presented at #ASCO25 has pointed to the efficacy of neoadjuvant/perioperative #gemcitabine with #cisplatin. 👉 The combination boosted OS and R0 resection rates in patients with biliary tract cancer: https://t.co/xe9FZsqYjF